Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 138 | $77,751,392 |
Sells | 179 | $97,046,544 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 03 Apr 2024 | Sale | 185 | 242 | 44,770 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 05 Apr 2024 | Sale | 5,278 | 245.5332 | 1,295,924 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 05 Apr 2024 | Sale | 2,079 | 244.4509 | 508,213 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 05 Apr 2024 | Sale | 8,817 | 242.6073 | 2,139,069 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 05 Apr 2024 | Sale | 8,989 | 243.3294 | 2,187,288 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 05 Apr 2024 | Sale | 700 | 241.1413 | 168,799 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 05 Apr 2024 | Sale | 1,643 | 240.1076 | 394,497 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 04 Apr 2024 | Sale | 100 | 248.23 | 24,823 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 04 Apr 2024 | Sale | 711 | 247.2268 | 175,778 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 04 Apr 2024 | Sale | 1,653 | 246.0123 | 406,658 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 04 Apr 2024 | Sale | 435 | 244.0066 | 106,143 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 04 Apr 2024 | Sale | 2,734 | 245.0643 | 670,006 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 04 Apr 2024 | Sale | 3,085 | 242.7114 | 748,765 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 04 Apr 2024 | Sale | 5,619 | 241.8528 | 1,358,971 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 04 Apr 2024 | Sale | 4,200 | 240.8759 | 1,011,679 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 03 Apr 2024 | Sale | 2,089 | 246.3249 | 514,573 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 03 Apr 2024 | Sale | 18,917 | 245.3356 | 4,641,014 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 03 Apr 2024 | Sale | 4,070 | 244.6815 | 995,854 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 03 Apr 2024 | Sale | 2,634 | 243.6849 | 641,866 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 03 Apr 2024 | Sale | 135 | 242 | 32,670 | D |
03 Apr 2024 20:47 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 01 Apr 2024 | Sale | 300 | 267.0733 | 80,122 | D |
03 Apr 2024 20:47 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 01 Apr 2024 | Sale | 713 | 265.2809 | 189,145 | D |
03 Apr 2024 20:47 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 01 Apr 2024 | Sale | 100 | 259.07 | 25,907 | D |
03 Apr 2024 20:47 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 01 Apr 2024 | Sale | 1,600 | 257.9347 | 412,696 | D |
03 Apr 2024 20:47 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 01 Apr 2024 | Sale | 4,387 | 255.899 | 1,122,629 | D |
03 Apr 2024 20:47 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 01 Apr 2024 | Sale | 3,900 | 256.881 | 1,001,836 | D |
03 Apr 2024 20:41 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 02 Apr 2024 | Sale | 200 | 248.4508 | 49,690 | D |
03 Apr 2024 20:41 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 02 Apr 2024 | Sale | 43 | 247.0342 | 10,622 | D |
03 Apr 2024 20:41 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 02 Apr 2024 | Sale | 557 | 246.2958 | 137,187 | D |
03 Apr 2024 20:41 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 02 Apr 2024 | Sale | 2,991 | 244.8946 | 732,480 | D |
03 Apr 2024 20:41 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 02 Apr 2024 | Sale | 6,279 | 244.1927 | 1,533,286 | D |
03 Apr 2024 20:41 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 02 Apr 2024 | Sale | 842 | 243.2559 | 204,821 | D |
03 Apr 2024 20:41 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 01 Apr 2024 | Sale | 274 | 266.9052 | 73,132 | D |
03 Apr 2024 20:41 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 01 Apr 2024 | Sale | 500 | 265.486 | 132,743 | D |
03 Apr 2024 20:41 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 01 Apr 2024 | Sale | 351 | 264.8908 | 92,977 | D |
03 Apr 2024 20:41 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 01 Apr 2024 | Sale | 178 | 263.3133 | 46,870 | D |
03 Apr 2024 20:41 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 01 Apr 2024 | Sale | 800 | 262.005 | 209,604 | D |
03 Apr 2024 20:41 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 01 Apr 2024 | Sale | 200 | 259.11 | 51,822 | D |
03 Apr 2024 20:41 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 01 Apr 2024 | Sale | 1,460 | 258.2834 | 377,094 | D |
03 Apr 2024 20:41 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 01 Apr 2024 | Sale | 3,604 | 257.2981 | 927,302 | D |
03 Apr 2024 20:41 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 01 Apr 2024 | Sale | 6,809 | 255.6366 | 1,740,630 | D |
03 Apr 2024 20:41 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 01 Apr 2024 | Sale | 7,401 | 256.5019 | 1,898,371 | D |
03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 02 Apr 2024 | Sale | 7 | 249.05 | 1,743 | D |
03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 02 Apr 2024 | Sale | 193 | 248.4887 | 47,958 | D |
03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 02 Apr 2024 | Sale | 100 | 246.8805 | 24,688 | D |
03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 02 Apr 2024 | Sale | 567 | 246.2028 | 139,597 | D |
03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 02 Apr 2024 | Sale | 7,048 | 244.2722 | 1,721,630 | D |
03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 02 Apr 2024 | Sale | 2,080 | 244.965 | 509,527 | D |
03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 02 Apr 2024 | Sale | 1,217 | 243.2823 | 296,075 | D |
03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 01 Apr 2024 | Sale | 274 | 266.9052 | 73,132 | D |
03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 01 Apr 2024 | Sale | 700 | 265.3557 | 185,749 | D |
03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 01 Apr 2024 | Sale | 116 | 264.7343 | 30,709 | D |
03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 01 Apr 2024 | Sale | 143 | 263.0816 | 37,621 | D |
03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 01 Apr 2024 | Sale | 200 | 259.13 | 51,826 | D |
03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 01 Apr 2024 | Sale | 841 | 262.1797 | 220,493 | D |
03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 01 Apr 2024 | Sale | 2,104 | 258.2412 | 543,339 | D |
03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 01 Apr 2024 | Sale | 2,790 | 257.3262 | 717,940 | D |
03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 01 Apr 2024 | Sale | 7,411 | 256.4904 | 1,900,850 | D |
03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 01 Apr 2024 | Sale | 6,698 | 255.6165 | 1,712,119 | D |
02 Mar 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 01 Mar 2023 | Sale | 100 | 276.19 | 27,619 | D |
02 Mar 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 01 Mar 2023 | Sale | 1,300 | 275.53 | 358,189 | D |
02 Mar 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 01 Mar 2023 | Sale | 1,672 | 274.57 | 459,081 | D |
02 Mar 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 01 Mar 2023 | Sale | 1,928 | 273.44 | 527,192 | D |
02 Mar 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 28 Feb 2023 | Sale | 4,100 | 272.3 | 1,116,430 | D |
02 Mar 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 28 Feb 2023 | Sale | 900 | 271.03 | 243,927 | D |
19 Jan 2023 19:57 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 17 Jan 2023 | Sale | 500 | 296.68 | 148,340 | D |
19 Jan 2023 19:57 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 17 Jan 2023 | Sale | 2,325 | 295.45 | 686,921 | D |
19 Jan 2023 19:57 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 17 Jan 2023 | Sale | 5,164 | 294.68 | 1,521,728 | D |
19 Jan 2023 19:57 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 17 Jan 2023 | Sale | 3,548 | 293.54 | 1,041,480 | D |
19 Jan 2023 19:57 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 17 Jan 2023 | Sale | 5,227 | 292.68 | 1,529,838 | D |
19 Jan 2023 19:57 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 17 Jan 2023 | Sale | 3,325 | 291.66 | 969,770 | D |
19 Jan 2023 19:57 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 17 Jan 2023 | Sale | 1,600 | 290.36 | 464,576 | D |
19 Jan 2023 19:57 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 17 Jan 2023 | Sale | 300 | 288.91 | 86,673 | D |
19 Jan 2023 19:57 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 17 Jan 2023 | Sale | 400 | 287.08 | 114,832 | D |
19 Jan 2023 19:57 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 17 Jan 2023 | Sale | 100 | 285.28 | 28,528 | D |
06 Jan 2023 09:08 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 03 Jan 2023 | Sale | 100 | 287.86 | 28,786 | D |
06 Jan 2023 09:08 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 03 Jan 2023 | Sale | 400 | 286.62 | 114,648 | D |
06 Jan 2023 09:08 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 03 Jan 2023 | Sale | 2,038 | 285.74 | 582,338 | D |
06 Jan 2023 09:08 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 03 Jan 2023 | Sale | 829 | 285.15 | 236,389 | D |
06 Jan 2023 09:08 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 03 Jan 2023 | Sale | 1,549 | 283.85 | 439,684 | D |
06 Jan 2023 09:08 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 03 Jan 2023 | Sale | 2,628 | 282.97 | 743,645 | D |
06 Jan 2023 09:08 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 03 Jan 2023 | Sale | 2,656 | 281.97 | 748,912 | D |
06 Jan 2023 09:08 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 03 Jan 2023 | Sale | 1,800 | 280.66 | 505,188 | D |
06 Jan 2023 09:08 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 03 Jan 2023 | Sale | 400 | 279.1 | 111,640 | D |
06 Jan 2023 09:08 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 03 Jan 2023 | Sale | 600 | 277.91 | 166,746 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 100 | 284.65 | 28,465 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 400 | 283.43 | 113,372 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 400 | 282.13 | 112,852 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 1,000 | 280.92 | 280,920 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 2,620 | 279.96 | 733,495 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 3,003 | 279.15 | 838,287 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 700 | 277.83 | 194,481 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 700 | 276.67 | 193,669 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 811 | 275.7 | 223,593 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 3,019 | 274.56 | 828,897 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 2,471 | 273.54 | 675,917 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 5,534 | 272.68 | 1,509,011 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 2,084 | 271.54 | 565,889 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 2,069 | 270.56 | 559,789 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 1,476 | 269.61 | 397,944 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)